| Financial Year |
March 31 2023 |
| Monetary Funds |
664,178,150.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,359,157.18 |
| Accounts Receivable |
141,972,781.06 |
| Advances to Suppliers |
35,588,462.02 |
| Other Receivables |
11,900,181.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
44,950,705.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,916,396.86 |
| Total Current Assets |
1,075,471,141.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,802,325.12 |
| Investment Properties |
52,085,869.04 |
| Fixed Assetes |
261,432,867.07 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,983,020.60 |
| R&D expenses |
7,204,153.77 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,462,720.59 |
| Deferred Income Tax Assets |
8,757,571.41 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
586,698,869.08 |
| Total Assets |
1,662,170,010.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
711,900.00 |
| Accounts Payable |
115,537,554.12 |
| Accounts Received In Advance |
283,774.21 |
| Employee Compensation Payable |
33,756,374.32 |
| Taxes Payable |
1,005,362.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,185,415.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,611,893.67 |
| Other Current Liabilities |
9,602,141.30 |
| Sub-Total of Current Liabilities |
196,386,196.29 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,623,387.04 |
| Deferred Income Tax Liabilities |
4,421,963.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,556,403.38 |
| Total Liabilities |
206,942,599.67 |
| Paid-In Capital(Or Share Stock) |
313,457,493.00 |
| Capital Surplus |
699,939,114.81 |
| Surplus Reserve |
69,017,405.36 |
| LESS:Treasury Stock |
64,187,106.08 |
| Undistributed Profits |
405,542,919.23 |
| Minority Stockholder's Interest |
7,031,935.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,448,195,474.52 |
| Owner's Equity（Stockholder's Equity） |
1,455,227,410.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,662,170,010.08 |
